News Center

位置：

Honors Announcement

Group News

Media Reports

Shijiazhuang Sihua Pharmaceutical Group Makes Its Debut at a Major Latin American Pharmaceutical Event

Category:

Group News

发布时间：2025-04-11

【概要描述】 From April 2 to 4, 2025, local time, the annual flagship event of the Latin American pharmaceutical industry—the 52nd Mexico Pharmaceutical Industry Exhibition (Expofarma)—was grandly held in Mexico City. Shijiazhuang Sihua Pharmaceutical Group showcased its key finished dosage forms and active pharmaceutical ingredients at the exhibition, actively expanding its presence in the Latin American market.

Shijiazhuang Sihua Pharmaceutical Group Makes Its Debut at a Major Latin American Pharmaceutical Event

From April 2 to 4, 2025, local time, the annual flagship event of the Latin American pharmaceutical industry—the 52nd Mexico Pharmaceutical Industry Exhibition (Expofarma)—was grandly held in Mexico City. Shijiazhuang Sihua Pharmaceutical Group showcased its key finished dosage forms and active pharmaceutical ingredients at the exhibition, actively expanding its presence in the Latin American market.

According to reports, as the largest and most influential specialized pharmaceutical exhibition in Latin America, it has evolved into a central platform for integrating resources across the region’s pharmaceutical industry value chain. Hosted by the Mexican Pharmaceutical Industry Association (AFMAC), the event showcases products spanning the entire industry spectrum—ranging from pharmaceutical raw materials and manufacturing equipment to medical devices and laboratory instruments—and draws more than 10,000 industry leaders, corporate representatives, and professional visitors from Mexico as well as North and South American countries, all coming together to explore emerging trends in the pharmaceutical sector.

At the exhibition, the Group’s booth prominently showcased its flagship products, including injectables, oral solid dosage forms, and specialty APIs, attracting considerable attention and fostering interest in potential collaborations among South American business visitors. A representative from the company’s international trade team stated: “The robust demand in the Mexican and broader Latin American pharmaceutical markets presents a rare opportunity to accelerate our global expansion. We will proactively align with local market-access regulations, ensure timely product registration, and drive further breakthroughs in the Group’s international operations.” During the event, the Group’s international trade team also held meetings with key Mexican partners, reaching several agreements on deepening supply-chain collaboration and developing customized products.

In recent years, the Group has anchored itself in the dual-circulation development strategy—both domestic and international—and has leveraged the integrated “API + formulation” development model along with the advantages brought by digital transformation in product portfolio, quality, cost efficiency, and international certifications to continuously enhance its global operations. As a result, its product exports have become increasingly diversified and are steadily scaling up.

“By leveraging international trade fairs and other platforms, we are proactively gathering intelligence on overseas market demand, engaging in global partnerships, and continuously enhancing our brand’s international visibility and influence, thereby steadily expanding our network of international business partners,” said the group’s head of foreign trade. “We will further identify more export-ready products with strong appeal in overseas markets and accelerate the transformation of our foreign trade operations—from product exports to brand exports.”

Keywords:

Young Scientists from Tsinghua University Visit Shijiazhuang Sihua Pharmaceutical Group for Inspection and Research

Shijiazhuang Sihua Pharmaceutical Group Makes Its Debut at CPHI Japan in Tokyo

Young Scientists from Tsinghua University Visit Shijiazhuang Sihua Pharmaceutical Group for Inspection and Research

Shijiazhuang Sihua Pharmaceutical Group Makes Its Debut at CPHI Japan in Tokyo